Alibaba Health

Alibaba Health, also known as AliHealth, is a Chinese healthcare company listed on the Hong Kong Stock Exchange and associated with Alibaba Group. Its principal corporate vehicle is Alibaba Health Information Technology Limited, while Alibaba Health is used as the public-facing name for Alibaba’s healthcare activities. The business focuses on digital health services and resources, with activities spanning pharmaceutical e-commerce, online healthcare, consumer healthcare and technology-enabled services for healthcare organizations. The company’s origins are connected to the listed Hong Kong retail company Shui Hing and the corporate succession that followed its sale, renaming and acquisition. In 2000, CITIC Group acquired the business then known as Easy Concepts and later renamed it CITIC 21CN. Alibaba and Yunfeng Capital acquired a controlling stake in CITIC 21CN in January 2014. The company was subsequently renamed Alibaba Health, creating a listed platform through which Alibaba could develop healthcare-related businesses. Alibaba said the target’s drug-data capabilities were relevant to its expansion into healthcare. Alibaba Health’s consumer-facing activities include online transactions involving medicines, medical devices and health products, together with healthcare information and service connections. Its online healthcare activities can connect users with healthcare resources, while its broader digital-health work supports healthcare-sector participants and operational processes. The exact mix of offerings can change with partnerships, regulation and Alibaba Group’s strategy. Pharmaceutical and medical activities are subject to requirements concerning product authorization, online medicine sales, prescriptions, professional practice, advertising, data use and platform operations. The company has also used acquisitions, investments and internal transfers to expand beyond a narrow online-pharmacy model. A proposed 2015 transfer of Alibaba’s online pharmacy operations from Tmall did not proceed after regulatory uncertainty affected the transaction. In 2018, Alibaba announced a new transfer of certain healthcare categories on Tmall to Alibaba Health. During the same period, Alibaba Health invested in several offline healthcare businesses, including Guizhou Ensure, ShuYu Civilian Pharmacy Corporation and Huaren Health, in an effort to develop more stable sources of cash flow. During the COVID-19 pandemic, the company reported stronger revenue from direct sales and recorded its first profitable year after reporting net losses since inception, according to the referenced account. In November 2023, it announced a proposed acquisition from Taobao involving AJK Technology Holding Ltd. The transaction was described as providing access to certain services connected with Alibaba’s marketing tools, with the stated objective of improving profitability. Alibaba Health therefore combines a listed-company structure with Alibaba ecosystem links in commerce, technology, payments and logistics, while operating in a highly regulated Chinese healthcare market.

Alibaba Health’s corporate history begins with Shui Hing, a Hong Kong retail company listed on the Hong Kong Stock Exchange in 1971. In 1998, Shui Hing was sold to fashion retailer Easyknit International Holdings and renamed Easy Concepts. CITIC Group acquired Easy Concepts in 2000, after which the business became associated with the CITIC 21CN name. The decisive change came in January 2014, when Alibaba and Yunfeng Capital acquired a controlling stake in CITIC 21CN. The transaction gave Alibaba an established listed vehicle through which it could develop healthcare activities. Contemporary speculation suggested that the deal might have been intended as a reverse takeover that could facilitate an Alibaba listing in Hong Kong, but accounts cited in the reference material state that Alibaba denied this purpose. Alibaba instead emphasized CITIC 21CN’s drug-data platform and its relevance to expansion in healthcare. The company was subsequently renamed Alibaba Health. Alibaba Health’s early strategic development involved attempts to combine Alibaba’s online commerce infrastructure with pharmaceutical and healthcare capabilities. In 2015, Alibaba agreed to transfer its online pharmacy operations from Tmall to Alibaba Health in exchange for newly issued shares and convertible bonds. The arrangement ultimately lapsed because of regulatory uncertainty surrounding online drug sales. The episode demonstrated the importance of China’s regulatory framework to the structure and timing of the company’s business expansion. In May 2018, Alibaba announced another transfer involving several healthcare categories on Tmall. Alibaba Health also made investments in offline healthcare companies during 2018, including Guizhou Ensure, ShuYu Civilian Pharmacy Corporation and Huaren Health. These investments reflected an effort to diversify beyond online activity, build relationships with physical healthcare and pharmacy businesses, and develop more dependable cash flows. The company had reported losses for multiple years, making profitability and business-model diversification important strategic concerns. The company’s business has since been described across several connected areas: pharmaceutical e-commerce, online healthcare, consumer healthcare and digital solutions for the healthcare sector. It operates through relationships with consumers, medicine and health-product suppliers, pharmacies, healthcare providers, pharmaceutical companies and other partners. Its role is not limited to selling products; it also uses digital platforms to provide information, facilitate access to healthcare resources and support industry processes. The scope and organization of individual services may change as regulations and Alibaba Group priorities evolve. The COVID-19 period brought increased revenue from direct sales, and Alibaba Health reported its first profitable year after recording net losses since inception. The pandemic highlighted the importance of online access to medicines and health products, while also increasing attention on compliance, fulfillment, medical claims and data governance. In November 2023, Alibaba Health stated that it would acquire AJK Technology Holding Ltd from Taobao. The proposed transaction was described as giving Alibaba Health access to certain services associated with Alibaba’s marketing tools, with the aim of improving profitability. This move illustrated the continuing connection between Alibaba Health and the wider Alibaba commercial technology ecosystem. Today, Alibaba Health remains a Hong Kong-listed healthcare platform focused primarily on China, operating at the intersection of digital commerce, medicine retail, online healthcare and healthcare-sector technology. Its activities remain subject to rules governing medicines, medical services, prescriptions, data and online platforms.

• 2023

  AJK Technology acquisition announced

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  Alibaba Health announced a proposed acquisition of AJK Technology Holding Ltd from Taobao to obtain certain marketing-tool services and support profitability.

• 2018

  Healthcare categories and offline investments expand

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  Alibaba announced a transfer of selected Tmall healthcare categories to Alibaba Health, while Alibaba Health invested in several offline healthcare businesses.

• 2015

  Online pharmacy transfer proposal lapses

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  A proposed transfer of Alibaba’s Tmall online pharmacy operations to Alibaba Health did not proceed because of regulatory uncertainty.

• 2014

  Alibaba and Yunfeng Capital acquire control

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  Alibaba and Yunfeng Capital acquired a controlling stake in CITIC 21CN, which was subsequently renamed Alibaba Health.

• 2000

  CITIC Group acquires Easy Concepts

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  CITIC Group acquired Easy Concepts, which was later renamed CITIC 21CN.

• 1998

  Shui Hing becomes Easy Concepts

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  After being sold to Easyknit International Holdings, Shui Hing was renamed Easy Concepts.

• 1971

  Shui Hing is listed in Hong Kong

  [1]Alibaba Health - Wikipediaen.wikipedia.org

  The corporate lineage that later led to Alibaba Health can be traced to Shui Hing, a Hong Kong retail company listed on the Hong Kong Stock Exchange.

A digital healthcare platform connecting consumers, medicines, healthcare resources and industry participants through Alibaba-related technology and commerce capabilities.

• Digital commerce

  Pharmaceutical e-commerce

  Alibaba Health’s pharmaceutical e-commerce activities connect consumers with medicines, medical devices and health products through online channels. The business can include product discovery, information, transaction facilitation and related fulfillment or platform services. Product availability and transaction processes depend on supplier qualifications, applicable medicine rules and the regulatory treatment of online sales.

• Digital healthcare services

  Online healthcare

  Online healthcare uses digital interfaces to provide healthcare information, consultation-related services or connections between users and healthcare resources. Depending on the specific service, this may involve providers, pharmacies or other healthcare partners. Delivery is constrained by rules concerning medical practice, prescriptions, professional responsibility and health-data handling.

• Consumer health

  Consumer healthcare

  Consumer healthcare covers selected health and medical-consumption scenarios for individuals. Alibaba Health can use online channels to present services, products and provider information and to connect consumers with participating organizations. The precise scope differs by market, partner and regulatory requirements.

• Healthcare technology

  Digital healthcare solutions

  Alibaba Health’s healthcare-technology activities support digitalization across parts of the healthcare industry. They may involve platforms, data capabilities, operational tools or other technology-enabled services for healthcare participants. The company’s original connection to drug-data capabilities and its relationship with Alibaba’s technology ecosystem are central elements of this positioning.

• 2024

  Source 1Source 2Source 3

Read more

• 2023

  Proposed acquisition of AJK Technology HoldingM&A

  Background

  Alibaba Health sought additional tools and capabilities that could support profitability within the Alibaba ecosystem.

  Action taken

  Alibaba Health stated that it would acquire AJK Technology Holding Ltd from Taobao.

  Aftermath

  The proposed deal was described as providing certain Alibaba marketing-tool services; the referenced material does not establish its final completion status.

  Reported acquisition consideration. US$1.73 billion (November 2023 announcement)

  Source

• 2018

  Transfer of selected Tmall healthcare categoriesStrategy

  Background

  Alibaba continued to reorganize healthcare-related commerce within its corporate ecosystem after the earlier online-pharmacy proposal lapsed.

  Action taken

  Alibaba announced that several healthcare categories on Tmall would be transferred to Alibaba Health.

  Aftermath

  The transfer strengthened Alibaba Health’s role in Alibaba’s healthcare commerce activities.

  Reported transaction consideration. US$1.35 billion (May 2018 announcement)

  Source

• 2018

  Investments in offline healthcare businessesM&A

  Background

  Alibaba Health had experienced losses and sought to broaden its business base and develop more stable cash flows.

  Action taken

  Alibaba Health invested in Guizhou Ensure, ShuYu Civilian Pharmacy Corporation and Huaren Health.

  Aftermath

  The investments expanded the company’s links with offline healthcare and pharmacy businesses.

  Source

• 2015

  Proposed transfer of Tmall online pharmacy operationsStrategy

  Background

  Alibaba attempted to consolidate its online pharmacy operations within Alibaba Health as part of its healthcare expansion.

  Action taken

  Alibaba agreed to transfer the operations from Tmall in exchange for newly issued Alibaba Health shares and convertible bonds.

  Aftermath

  Alibaba Health allowed the arrangement to lapse because regulatory uncertainty made the online drug-sales structure difficult to complete.

  Proposed consideration. US$2.5 billion in newly issued shares and convertible bonds (2015 proposal)

  Source

• 2014

  Acquisition of controlling stake in CITIC 21CNM&A

  Background

  Alibaba sought to expand into healthcare and identified CITIC 21CN’s drug-data platform as strategically relevant.

  Action taken

  Alibaba and Yunfeng Capital acquired a controlling stake in CITIC 21CN, which was later renamed Alibaba Health.

  Aftermath

  The transaction established the listed corporate platform that became Alibaba’s healthcare unit.

  Reported acquisition consideration. US$170 million (January 2014 transaction)

  Source

• 2023

  Alibaba Health announces proposed acquisition of AJK Technology[1]Alibaba Health - Wikipediaen.wikipedia.org

  M&A

  Alibaba Health announced that it would acquire AJK Technology Holding Ltd from Taobao. The transaction was described as providing certain Alibaba marketing-tool services intended to support profitability.

• 2018

  Alibaba announces transfer of healthcare categories from Tmall[1]Alibaba Health - Wikipediaen.wikipedia.org

  M&A

  Alibaba announced that several healthcare categories on Tmall would be transferred to Alibaba Health, strengthening the listed company’s role within Alibaba’s healthcare business.

• 2018

  Alibaba Health invests in offline healthcare companies[1]Alibaba Health - Wikipediaen.wikipedia.org

  M&A

  Alibaba Health made investments involving Guizhou Ensure, ShuYu Civilian Pharmacy Corporation and Huaren Health as it sought to broaden its offline healthcare presence and improve the stability of cash generation.

• 2015

  Proposed transfer of Tmall online pharmacy operations lapses[1]Alibaba Health - Wikipediaen.wikipedia.org

  Regulation

  Alibaba proposed transferring its online pharmacy operations from Tmall to Alibaba Health, but the arrangement lapsed amid regulatory uncertainty concerning online drug sales.

• 2014

  Alibaba and Yunfeng Capital acquire control of CITIC 21CN[1]Alibaba Health - Wikipediaen.wikipedia.org

  M&A

  Alibaba and Yunfeng Capital acquired a controlling stake in CITIC 21CN. The transaction provided Alibaba with a listed healthcare-related platform and access to drug-data capabilities.

• 2014

  Alibaba Health name adopted after CITIC 21CN transaction[1]Alibaba Health - Wikipediaen.wikipedia.org

  Other

  CITIC 21CN was renamed Alibaba Health after the change in control, establishing the name used for Alibaba’s listed healthcare platform.

• Alibaba Health reports first profitable year during the COVID-19 period[1]Alibaba Health - Wikipediaen.wikipedia.org

  Other

  During the COVID-19 pandemic, Alibaba Health’s revenue increased through direct sales, and the company reported its first profitable year after recording annual net losses since inception.

1. 1Alibaba Health - Wikipediaen.wikipedia.org
2. 2Alibaba Health official websitealibabahealth.com
3. 3阿里健康大药房违法广告、虚假宣传多次被罚jiemian.com
4. 4阿里健康大药房违法广告、虚假宣传多次被罚ccn.com.cn
5. 5阿里健康大药房违法广告、虚假宣传多次被罚finance.sina.com.cn
6. 6阿里健康(00241)收购医药核心资产，顺势加码互联网医疗finance.sina.com.cn
7. 7阿里健康80.75亿港元收购控股公司全部股权finance.sina.com.cn
8. 8针对湖北慢病患者缺药难题 阿里巴巴上线“缺药登记”服务finance.sina.com.cn
9. 9针对湖北慢病患者缺药难题 阿里巴巴上线“缺药登记”服务tech.sina.com.cn